Opiate Receptors and Antagonists: From Bench to Clinic by Reginald DeanOpiate Receptors and Antagonists: From Bench to Clinic by Reginald Dean

Opiate Receptors and Antagonists: From Bench to Clinic

byReginald DeanEditorEdward J. Bilsky, S. Stevens Negus

Paperback | November 19, 2010

Pricing and Purchase Info

$296.64 online 
$343.95 list price save 13%
Earn 1,483 plum® points

Prices and offers may vary in store


In stock online

Ships free on orders over $25

Not available in stores


The evolution in our understanding of opioid receptors and their subtypes is in- mately linked to the development of new pharmacological treatments for diseases/ disorders as diverse as addiction, self-injurious behavior, pain, cancer, infl- mation, eating disorders, traumatic injury, pruritis, and movement disorders. These potential treatments involve both novel chemical entities and classic opioid antagonists with improved drug delivery systems. The contributions contained in Opioid Receptors and Antagonists: From Bench to Clinic represent the efforts from some of the leading international scientists and clinicians making use of the l- est information emerging from the study of the opioid receptor system. Given the number of researchers currently active in this and related fields of study, it would be inappropriate to suggest that the entire range of activities is fully reflected in this single volume. Instead, a variety of experimental and clinical approaches involving the fields of neuroscience, molecular biology, biochemistry, anatomy, pharmacology, psychology, and psychiatry have been chosen to illustrate rapidly developing experimental and therapeutic areas.
Title:Opiate Receptors and Antagonists: From Bench to ClinicFormat:PaperbackDimensions:757 pages, 22.9 × 15.2 × 0.01 inPublished:November 19, 2010Publisher:Springer-Verlag/Sci-Tech/TradeLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:1617378224

ISBN - 13:9781617378225

Look for similar items by category:


Table of Contents

OPIOID RECEPTORS.- Ultra-Low Dose Opioid Antagonists Enhance Opioid Analgesia and Reduce Tolerance.- Upregulation of Opioid Receptors.- Imaging Human Brain Opioid Receptors: Applications to Substance Use Disorders.- Opioid Receptor Antagonists-Mediated Signaling in Immune System.- OPIOID ANTAGONISTS: CHEMISTRY AND PHARMACOLOGY.- The Chemistry and Pharmacology of Mu Opioid Antagonists.- Medicinal Chemistry of Kappa Antagonists.- The Pharmacology of Delta Opioid Antagonists.- Novel Opioid Antagonists with Mixed/Dual Selectivity.- Experimental Utility and Clinical Potential of Irreversible Opioid Antagonists.- Methylnaltrexone: A Peripherally Acting Opioid Antagonist.- SUBSTANCE ABUSE.- Opioid Antagonist Effects in Animal Models Related to Opioid Abuse: Drug Discrimination and Drug Self-Administration.- Naltrexone for Initiation and Maintenance of Opiate Abstinence.- Ultra-Low Dose Naltrexone Decreases Dependence and Addictive Properties of Opioids.- Can a Combination Formulation Containing a Neutral Opiate Antagonist Decrease the Abuse of µ-Agonist Opiates?.- Effects of Opioid Antagonists on the Abuse-Related Effects of Psychomotor Stimulants and Nicotine.- Potential Use of Opioid Antagonists in the Treatment of Marijuana Abuse and Dependence.- Naltrexone in Smoking Cessation: A Review of the Literature and Future Directions.- ALCOHOL AND INGESTIVE BEHAVIORS.- Opioid Antagonists and Ethanol's Ability to Reinforce Intake of Alcoholic Beverages: Preclinical Studies.- Clinical Use of Opioid Antagonists in the Treatment of Alcohol Dependence.- Preclinical Effects of Opioid Antagonists on Feeding and Appetite.- CNS Opiate Systems and Eating Disorders.- BEHAVIORAL DISORDERS.- Potential Utility of Kappa Ligands in the Treatment of Mood Disorders.- Opioid Antagonists in the Treatment of Pathological Gambling and Kleptomania.- Efficacy of Opioid Antagonists in Attenuating Self-Injurious Behavior.- Pharmacotherapeutic Effects of OpioidAntagonists in Alcohol Abusing Patients with Schizophrenia.- MEDICAL INDICATIONS.- Current Issues in the Use of Opioid Antagonists.- Emergency Room Use of Opioid Antagonists in Drug Intoxication and Overdose.- Kappa Opioid Antagonists as Pruritogenic Agents.- Clinical Effect of Opioid Antagonists on Clinical Pruritus.- Effects of Opioid Antagonists on L-Dopa-Induced Dyskinesia in Parkinson's Disease.- Endocrine Effects of Opioid Antagonists.- Opioid Antagonists in Traumatic Shock: Animal and Human Studies.- The Efficac y of Opioid Antagonists against Heatstroke-Induced Ischemia and Injury in Rats.- A Review of the Opioid System in Cancer Patients and Preliminary Results of Opioid Antagonists in the Treatment of Human Neoplasm.- DRUG DELIVERY APPROACHES.- Non-Clinical Pharmacology of VIVITROL®: A Monthly Injectable Naltrexone for the Treatment of Alcohol Dependence.- The Development of Sustained Release Naltrexone and Clinical Use in Treating Opiate Dependency.- The Development of Proneura Technology for the Treatment of Addictions.- Development of Opioid Transdermal Delivery Systems.- Intranasal Naloxone for Treatment of Opioid Overdose.

Editorial Reviews

From the reviews:"The authors do an excellent job of providing insight into the background of the many factors related to opioid receptor antagonists. . Overall, this work is a well written and interesting text and would be a very useful addition to the personal libraries of those medicinal chemists with a research interest in the modulation of the opioid receptor system." (Thomas E. Prisinzano, Journal of Medicinal Chemistry, Vol. 53 (2), March, 2010)"This book is focused on the therapeutic uses of opioid antagonists ranging from classical opioid antagonists to novel chemical entities. In any therapeutic field examined, the aim of book as outlined by the title-'From Bench to Clinic'-is achieved. . The clinical applications of opioid antagonists are extensively discussed in almost all chapters of this book . . In conclusion, this book gives an interesting analysis of the different fields of knowledge and research concerning therapeutic uses of opioid antagonists in recent years." (Agostino Marrazzo, ChemBioChem, Vol. 5, 2010)